Table 3.
Relationships of immunohistochemical staining of CD4+/CD25+ Treg cells with different groups.
| Hemorrhagic transformation∗∗ | Gender | TOAST | OCSP | Interventional methods | mRS | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| With | Without | Male | Female | LAA | CE | Anterior circulation | Posterior circulation | Bridging therapy | Direct Thrombectomy | 0-2 | 3-6 | |
| CD4+ | 2 | 13 | 3.5 | 11.6 | 8 | 8.4 | 8.7 | 6.0 | 7.9 | 8.6 | 9.8 | 5.9 |
| CD25+ | 3 | 11 | 5.8 | 11.8 | 5 | 7.8 | 7.8 | 7.0 | 5.0 | 6.5 | 9.5 | 4.8 |
| CD4+CD25+ | 1.4 | 8.9 | 3.2 | 7.5 | 4.5 | 7.8 | 5 | 4 | 3 | 5.2 | 5.7 | 2 |
TOAST: Trial of Org 10172 in Acute Stroke Treatment; LAA: large atherosclerotic; CE: Cardioembolic; OCSP: Oxfordshire Community Stroke Project; mRS: modified Rankin Scale. ∗∗p < 0.001.